Skip to main content

Advertisement

SpringerLink
Log in

Quality-of-Life Measurements Versus Disease Activity in Systemic Lupus Erythematosus

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE) is a chronic disease affecting the physical, social, and psychological well-being of patients. Different instruments have been developed to measure health-related quality of life, some of which are SLE-specific. Contributors to poor quality of life in patients with SLE include fatigue, fibromyalgia, depression, and cognitive dysfunction. Health-related quality of life is not strongly associated with disease activity or organ damage. The Medical Outcomes Survey Short Form 36 is the most common instrument used to measure quality of life in SLE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Gladman DD, Urowitz MB, Ong A, et al.: Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 1996, 14:305–308.

    CAS  PubMed  Google Scholar 

  2. Ware JE Jr, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36). Conceptual framework and item selection. Med Care 1992, 30:473–483.

    Article  PubMed  Google Scholar 

  3. Alarcon G, McGwin G, Uribe A, et al.: Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum 2004, 51:465–474.

    Article  PubMed  Google Scholar 

  4. Godaert G, Hartkamp A, Geenen R, et al.: Fatigue in daily life in patients with primary Sjogren’s syndrome and systemic lupus erythematosus. Ann N Y Acad Sci 2002, 966:320–326.

    Article  CAS  PubMed  Google Scholar 

  5. Bruce I, Mak V, Hallett D, et al.: Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis 1999, 58:379–381.

    Article  CAS  PubMed  Google Scholar 

  6. Tench CM, McCurdie I, White PD, D’Cruz D: The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology 2000, 39:1249–1259.

    Article  CAS  PubMed  Google Scholar 

  7. Krupp L, LaRocca N, Muir J, Steinberg A: A study of fatigue in systemic lupus erythematosus. J Rheumatol 1990, 17:1450–1453.

    CAS  PubMed  Google Scholar 

  8. McKinley P, Ouellette S, Winkel G: The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. Arthritis Rheum 1995, 38:826–834.

    Article  CAS  PubMed  Google Scholar 

  9. Dobkin P, DaCosta D, Fortin P, et al.: Living with lupus: a prospective pan-Canadian study. J Rheumatol 2001, 28:2442–2448.

    CAS  PubMed  Google Scholar 

  10. Hanly JG, Fisk JD, McCurdy G, et al.: Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 2005, 32:1459–1466.

    PubMed  Google Scholar 

  11. Iverson GL, Sawyer DC, McCracken LM, Kozora E: Assessing depression in systemic lupus erythematosus: determining reliable change. Lupus 2001, 10:266–271.

    Article  CAS  PubMed  Google Scholar 

  12. Gladman DD, Urowitz MB, Gough J, MacKinnon A: Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 1997, 24:2145–2148.

    CAS  PubMed  Google Scholar 

  13. Greco C, Rudy T, Manzi S: Effects of disease activity, pain, and distress on activity limitations in patients with systemic lupus erythematosus. J Rheumatol 2004, 31:260–267.

    PubMed  Google Scholar 

  14. • Petri M, Naqibuddin M, Carson KA, et al.: Cognitive function in a systemic lupus erythematosus cohort. J Rheumatol 2008, 35:1776–1781. We showed marked cognitive dysfunction in newly diagnosed SLE patients. Cognitive dysfunction is an important contributor to poor quality of life among SLE patients.

    Article  PubMed  Google Scholar 

  15. Omdal R, Waterloo K, Koldingsnes W, et al.: Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects. J Rheumatol 2003, 30:283–287.

    PubMed  Google Scholar 

  16. Jump R, Robinson ME, Armstrong A, et al.: Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression and perceived social support. J Rheumatol 2005, 32:1699–1705.

    PubMed  Google Scholar 

  17. Daltroy LH, Robb-Nicholson C, Iversen MD, et al.: Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. Br J Rheumatol 1995, 34:1064–1069.

    Article  CAS  PubMed  Google Scholar 

  18. Tench CM, McCarthy J, McCurdie I, et al.: Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology (Oxford) 2003, 42:1050–1054.

    Article  CAS  Google Scholar 

  19. • Avina-Zubieta JA: Ad hoc committee on systemic lupus erythematosus response criteria for fatigue. Measurement of fatigue in systemic lupus erythematosus: a systematic review. Arthritis Rheum 2007, 57:1348–1357. This is a detailed review of different instruments used to measure fatigue in SLE patients.

    Article  Google Scholar 

  20. Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicentre criteria committee. Arthritis Rheum 1990, 33:160–172.

    Article  CAS  PubMed  Google Scholar 

  21. Lawrence RC, Helmick CG, Arnett FC, et al.: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41:778–799.

    Article  CAS  PubMed  Google Scholar 

  22. Wolfe F, Ross K, Anderson J, et al.: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995, 38:19–28.

    Article  CAS  PubMed  Google Scholar 

  23. Middleton GD, McFarlin JE, Lipsky PE: The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 1994, 37:1181–1188.

    Article  CAS  PubMed  Google Scholar 

  24. Romano TJ: Fibromyalgia prevalence in patients with systemic lupus erythematosus. Arthritis Rheum 1995, 38:118.

    Article  Google Scholar 

  25. Buskila D, Press J, Abu-Shakra M: Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol 2003, 25:25–28.

    Article  PubMed  Google Scholar 

  26. Da Costa D, Dobkin PL, Fitzcharles MA, et al.: Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol 2000, 27:365–372.

    PubMed  Google Scholar 

  27. Schlenk EA, Erlen JA, Dunbar Jacob J, et al.: Health related quality of life in chronic disorders: a comparison across studies using the MOS SF36. Qual Life Res 1998, 7:57–65.

    Article  CAS  PubMed  Google Scholar 

  28. Abu-Shakra M, Mader R, Langevitz P, et al.: Quality of life in systemic lupus erythematosus: a controlled study. J Rheumatol 1999, 26:306–309.

    CAS  PubMed  Google Scholar 

  29. Ledingham J, Dohertz S, Dohertz M: Primary fibromyalgia syndrome—an outcome study. Br J Rheumatol 1993, 32:139–142.

    Article  CAS  PubMed  Google Scholar 

  30. Burckhardt CS, Clark SR, Bennett RM: Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993, 20:475–479.

    CAS  PubMed  Google Scholar 

  31. Wolfe F, Anderson J, Harkness D, et al.: Health status and disease severity in FM: results of a six-center longitudinal study. Arthritis Rheum 1997, 40:1571–1579.

    Article  CAS  PubMed  Google Scholar 

  32. Utset TO, Golden M, Petri M, et al.: Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjogren’s syndrome. J Rheumatol 1994, 21:2039–2045.

    CAS  PubMed  Google Scholar 

  33. Rinaldi S, Doria A, Ermani M, et al.: Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology 2004, 43:1580–1586.

    Article  PubMed  Google Scholar 

  34. Wilson I, Cleary P: Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995, 273:59–65.

    Article  CAS  PubMed  Google Scholar 

  35. Liang M, Rogers M, Larson M, et al.: The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1984, 27:13–19.

    Article  CAS  PubMed  Google Scholar 

  36. Carbotte RM, Denburg SD, Denburg JA: Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986, 174:357–364.

    Article  CAS  PubMed  Google Scholar 

  37. Hanly JG, Fisk JD, Sherwood G, et al.: Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992, 19:562–567.

    CAS  PubMed  Google Scholar 

  38. Hay EM, Black D, Huddy A, et al.: Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992, 35:411–416.

    Article  CAS  PubMed  Google Scholar 

  39. Leritz E, Brandt J, Petri M, et al.: “Subcortical” cognitive impairment in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 2000, 6:821–825.

    Article  CAS  PubMed  Google Scholar 

  40. Kirk A, Kertesz A, Polk MJ: Dementia with leukoencephalopathy in systemic lupus erythematosus. Can J Neurol Sci 1991, 18:344–348.

    CAS  PubMed  Google Scholar 

  41. Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA: The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 1997, 3:377–386.

    CAS  PubMed  Google Scholar 

  42. Denburg JA, Carbotte RA, Denburg SD: Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 1987, 37:464–467.

    CAS  PubMed  Google Scholar 

  43. Hanly JG, Behmann S, Denburg SD, et al.: The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus. Postgrad Med J 1989, 65:622–627.

    Article  CAS  PubMed  Google Scholar 

  44. Denburg SD, Carbotte RM, Denburg JA: Cognitive impairment in SLE: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 1987, 19:323–339.

    Article  Google Scholar 

  45. Wang C, Mayo NE, Fortin PR: The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 2001, 28:525–532.

    CAS  PubMed  Google Scholar 

  46. Gordon C, Clarke A: Quality of life and economic evaluation in SLE clinical trials. Lupus 1999, 8:645–654.

    Article  CAS  PubMed  Google Scholar 

  47. Fortin PR, Abrahamowicz M, Neville C, et al.: Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998, 7:101–107.

    Article  CAS  PubMed  Google Scholar 

  48. Gilboe I, Kvien T, Husby G: Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol 1999, 26:1694-1700.

    CAS  PubMed  Google Scholar 

  49. Sutcliffe N, Clarke A, Levinton C, et al.: Associates of health status in patients with systemic lupus erythematosus. J Rheumatol 1999, 26:2352–2356.

    CAS  PubMed  Google Scholar 

  50. Benitha R, Mohammed T: Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 2007, 26:24–29.

    Article  PubMed  Google Scholar 

  51. Stoll T, Gordon C, Seifert B, et al.: Consistency and validity of patient administered assessment of quality of life by the MOSF SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997, 24:1608–1614.

    CAS  PubMed  Google Scholar 

  52. Thumboo J, Fong K, Ng T, et al.: Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol 1999, 26:97–102.

    CAS  PubMed  Google Scholar 

  53. Gladman DD, Urowitz MB, Ong A, et al.: A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 1996, 5:190–195.

    Article  CAS  PubMed  Google Scholar 

  54. Pincus T, Summey J, Soraci SJ, et al.: Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983, 26:1346–1353.

    Article  CAS  PubMed  Google Scholar 

  55. Bergner M, Bobbitt RA, Carter WB, et al.: The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981, 19:787–805.

    Article  CAS  PubMed  Google Scholar 

  56. EuroQoL—a new facility for the measurement of health-related quality of life. The EuroQoL Group. Health Policy 1990, 16:199–208.

    Google Scholar 

  57. • McElhone K, Abbott J, Shelmerdine J, et al.: Development and validation of a disease-specific health-related quality of life measure, the LupusQoL, for adults with systemic lupus erythematosus. Arthritis Rheum 2007, 15:972–979. This article reviews a “lupus-specific” instrument, its development, and its validation.

    Article  Google Scholar 

  58. Grootscholten C, Ligtenberg G, Derksen RH, et al.: Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist. Qual Life Res 2003, 12:635–644.

    Article  CAS  PubMed  Google Scholar 

  59. Leong KP, Kong KO, Thong BY, et al.: Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQoL). Rheumatology (Oxford) 2005, 44:1267–1276.

    Article  CAS  Google Scholar 

  60. Wiginton KL: Illness representations: mapping the experience of lupus. Health Educ Behav 1999, 26:443–453.

    Article  CAS  PubMed  Google Scholar 

  61. Kong KO, Ho HJ, Howe HS, et al.: Cross-cultural adaptation of the Systemic Lupus Erythematosus Quality of Life Questionnaire into Chinese. Arthritis Rheum 2007, 57:980–985.

    Article  PubMed  Google Scholar 

  62. Ware J: SF-36 health survey update. Spine 2000, 25:3130–3139.

    Article  PubMed  Google Scholar 

  63. Sutcliffe N, Clarke AE, Gordon C, et al.: The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology 1999, 38:1130–1137.

    Article  CAS  PubMed  Google Scholar 

  64. Fortin PR, Abrahamowickz M, Neville C, et al.: Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998, 7:101–107.

    Article  CAS  PubMed  Google Scholar 

  65. Khanna S, Pal H, Pandey RM, Handa R: The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology 2004, 43:1536–1540.

    Article  CAS  PubMed  Google Scholar 

  66. Wang H, Mayo N, Fortin P: The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 2001, 28:525–532.

    CAS  PubMed  Google Scholar 

  67. Alarcon G, McGwin G Jr, Uribe A, et al.: Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self reported health-related quality of life early in the disease course. Arthritis Rheum 2004, 51:465–474.

    Article  PubMed  Google Scholar 

  68. Friedman A, Alarcon G, Mcgwin G, et al.: Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study. Arthritis Care Res 1999, 12:256–266.

    Article  CAS  PubMed  Google Scholar 

  69. Dorsey R, Andresen E, Moore T: Health-related quality of life and support group attendance for patients with systemic lupus erythematosus. J Clin Rheumatol 2004, 10:6–9.

    Article  PubMed  Google Scholar 

  70. Rinaldi S, Doria A, Salaffi F, et al.: Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatology 2004, 43:1574–1579.

    Article  CAS  PubMed  Google Scholar 

  71. Juenger J, Schellberg D, Kraemer S, et al.: Health-related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002, 87:235–241.

    Article  CAS  PubMed  Google Scholar 

  72. Ragsdale D, Morrow J: Quality of life as a function of HIV classification. Nurs Res 1990, 39:355–359.

    Article  CAS  PubMed  Google Scholar 

  73. Ariza-Ariza R, Hernandez-Cruz B, Navarro-Sarrabia F: EuroQoL is a useful instrument for assessing the health related quality of life of the patients with systemic lupus erythematosus. Lupus 2005, 14:334–335.

    Article  CAS  PubMed  Google Scholar 

  74. Luo N, Chew LH, Fong KY, et al.: Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Qual Life Res 2003, 12:87–92.

    Article  CAS  PubMed  Google Scholar 

  75. Luo N, Chew LH, Fong KY, et al.: Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore. Ann Acad Med Singapore 2003, 32:685–690.

    CAS  PubMed  Google Scholar 

  76. Wolfe F: Health-status questionnaires. Rheum Dis Clin North Am 1995, 21:445–464.

    CAS  PubMed  Google Scholar 

  77. Hochberg MC, Sutton JD: Physical-disability and psychosocial dysfunction in systemic lupus erythematosus. J Rheumatol 1988, 15:959–964.

    CAS  PubMed  Google Scholar 

  78. Milligan SE, Hom DL, Ballou SP, et al.: An assessment of the health assessment questionnaire functional ability index among women with systemic lupus erythematosus. J Rheumatol 1993, 20:972–996.

    CAS  PubMed  Google Scholar 

  79. DeBruin AF, De Witte LP, Stevens F, et al.: Sickness Impact Profile: the state of the art of a generic functional status measure. Soc Sci Med 1992, 35:1003–1014.

    Article  CAS  Google Scholar 

  80. Wysenbeek A, Leibovici L, Weinberger A, Guedj D: Fatigue in systemic lupus erythematosus. Prevalence and relation to disease expression. Br J Rheumatol 1993, 32:633–635.

    Article  CAS  PubMed  Google Scholar 

  81. Zonana-Nacach A, Roseman J, McGwin G Jr, et al.: Systemic lupus erythematosus in three ethnic groups VI Factors associated with fatigue within 5 years of criteria diagnosis. Lupus 2000, 9:101–109.

    Article  CAS  PubMed  Google Scholar 

  82. Da Costa D, Clarke A, Dobkin P, et al.: The relationship between health status, social support and satisfaction with medical care among patients with systemic lupus erythematosus. Int J Qual Health Care 1999, 11:201–207.

    Article  PubMed  Google Scholar 

  83. Bae S, Hashimoto H, Karlson E, et al.: Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol 2001, 28:1245–1250.

    CAS  PubMed  Google Scholar 

  84. Devins GM, Edworthy SM: Illness intrusiveness explains race-related quality-of-life differences among women with systemic lupus erythematosus. Lupus 2000, 9:534–541.

    Article  CAS  PubMed  Google Scholar 

  85. Stoll T, Kauer Y, Buchi S, et al.: Prediction of depression in systemic lupus erythematosus patients using SF-36 mental health scores. Rheumatology 2001, 40:695–698.

    Article  CAS  PubMed  Google Scholar 

  86. Thumboo J, Fong K, Chan S, et al.: A prospective study of factors affecting quality of life in systemic lupus erythematosus. J Rheumatol 2000, 27:1414–1420.

    CAS  PubMed  Google Scholar 

  87. Doninger N, Fink J, Utset T: Neuropsychologic functioning and health status in systemic lupus erythematosus. Does ethnicity matter? J Clin Rheumatol 2005, 11:250–256.

    Article  PubMed  Google Scholar 

  88. Regidor E, Barrio G, De la Fuente L, et al.: Association between educational level and health related quality of life in Spanish adults. J Epidemiol Community Health 1999, 53:75–82.

    Article  CAS  PubMed  Google Scholar 

  89. Ward M: Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels. Arthritis Rheum 2004, 51:616–624.

    Article  PubMed  Google Scholar 

  90. Hanly JG: Disease activity, cumulative damage and quality of life in systemic lupus erythematosus: results of a cross-sectional study. Lupus 1997, 6:243–247.

    Article  CAS  PubMed  Google Scholar 

  91. Dobkin P, Da Costa D, Dritsa M, et al.: Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res 1999, 12:402–410.

    Article  Google Scholar 

  92. Jolly M, Utset TO: Can disease specific measures for systemic lupus erythematosus predict patients’ health related quality of life? Lupus 2004, 13:924–926.

    Article  CAS  PubMed  Google Scholar 

  93. Thumboo F, Fong KY, Ng T-P, et al.: Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol 1999, 26:97–102.

    CAS  PubMed  Google Scholar 

  94. • Kuriya B, Gladman DD, Ibanez D, Urowitz MB: Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 2008, 59:181–185. This article shows FM to be an important contributor to poor quality of life in SLE patients, as measured by the SF-36.

    Article  PubMed  Google Scholar 

  95. Burckhardt CS, Archenholtz B, Bjelle A: Measuring the quality of life of women with rheumatoid arthritis or systemic lupus erythematosus: a Swedish version of the Quality of Life Scale (QOLS). Scand J Rheumatol 1992, 21:190–195.

    Article  CAS  PubMed  Google Scholar 

  96. Strand V, Aranow C, Cardiel MH, et al.: Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo. Lupus 2003, 12:677–686.

    Article  CAS  PubMed  Google Scholar 

  97. Nordmark G, Bengtsson C, Larsson A, et al.: Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Autoimmunity 2005, 38:531–540.

    Article  CAS  PubMed  Google Scholar 

  98. Petri M, Kim M, Kalunian K, et al.: Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005, 353:2550–2558.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by the Hopkins Lupus Cohort (NIH AR 43727) and by grant no. UL1 RR 025005 from the National Center for Research Resources.

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Johns Hopkins University School of Medicine, 1830 East Monument Street, Suite 7500, Baltimore, MD, 21205, USA

    Adnan N. Kiani & Michelle Petri

Authors
  1. Adnan N. Kiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle Petri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michelle Petri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiani, A.N., Petri, M. Quality-of-Life Measurements Versus Disease Activity in Systemic Lupus Erythematosus. Curr Rheumatol Rep 12, 250–258 (2010). https://doi.org/10.1007/s11926-010-0114-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-010-0114-1

Keywords

Search

Navigation